University of Bristol - Explore Bristol Research. Peer reviewed version. Link to published version (if available): /jvim.

Similar documents
Acute kidney injury (AKI) is defined as a sudden

Urinary biomarkers in acute kidney injury. Max Bell MD, PhD Karolinska University Hospital Solna/Karolinska Institutet

changing the diagnosis and management of acute kidney injury

Acute Kidney Injury for the General Surgeon

Neutrophil Gelatinase-Associated Lipocalin as a Biomarker of Acute Kidney Injury in Patients with Morbid Obesity Who Underwent Bariatric Surgery

Heart Failure and Cardio-Renal Syndrome 1: Pathophysiology. Biomarkers of Renal Injury and Dysfunction

ENDPOINTS FOR AKI STUDIES

NGAL, a new markers for acute kidney injury

AKI: definitions, detection & pitfalls. Jon Murray

Citation for the original published paper (version of record):

Acute kidney injury (AKI) is characterized by a

Grading of acute kidney injury(2013)

Acute Kidney Injury in Trauma. David Lee Skinner MBChB FCS(SA) Trauma Unit Inkosi Albert Luthuli Central Hospital KwaZulu Natal South Africa

Interest of NGAL as early marker of Acute Kidney Injury CLINIQUES UNIVERSITAIRES SAINT-LUC

Fluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI)

Acute Kidney Injury. Amandeep Khurana, MD Southwest Kidney Institute

The NGAL Turbidimetric Immunoassay Reagent Kit

SUPPLEMENTARY INFORMATION

Non-protein nitrogenous substances (NPN)

Preoperative Serum Bicarbonate Levels Predict Acute Kidney Iinjry after Cardiac Surgery

Novel Kidney Injury Biomarker Detected Subclinical Renal Injury in Severely Obese Adolescents with Normal Kidney Function

NGAL. Changing the diagnosis of acute kidney injury. Key abstracts

Paul R. Bowlin, M.D. University of Colorado Denver. May 12 th, 2008

Biomarkers for the Prevention of Drug Induced AKI (D-AKI)

International Journal of Advanced Research in Biological Sciences ISSN: Coden: IJARQG(USA) Research Article

Optimal Use of Iodinated Contrast Media In Oncology Patients. Focus on CI-AKI & cancer patient management

University of Groningen. Acute kidney injury after cardiac surgery Loef, Berthus Gerard

DEFINITION, CLASSIFICATION AND DIAGNOSIS OF ACUTE KIDNEY INJURY

What the ED clinician needs to know about SEPSIS - 3. Anna Morgan Consultant EM Barts Health

A08 Using Kidney Biomarkers for AKI 2: Differential Diagnosis, Interventions and Prognosis

Biomarkers of renal diseases. By Dr. Gouse Mohiddin Shaik

Sepsis: Identification and Management in an Acute Care Setting

EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz

Accepted Manuscript. Epidemiology of Cardiac Surgery Associated Acute Kidney Injury. Eric AJ. Hoste, Wim Vandenberghe

The incidence of acute kidney injury (AKI)

Discovery & Validation of Kidney Injury Biomarkers

NGAL Connect to the kidneys

Novel Biomarkers in Critically Ill Patients and the Emergency Room

JMSCR Vol 06 Issue 12 Page December 2018

Early-goal-directed therapy and protocolised treatment in septic shock

International Journal of Medical and Health Sciences

Sepsis. Reliability- can we achieve Dr Ron Daniels

JMSCR Vol 04 Issue 12 Page December 2016

1. Staging of CKD based on blood creatinine concentration

Prognostic role of adrenomedullin in sepsis

** Accordingly GFR can be estimated by using one urine sample and do creatinine testing.

Acute Kidney Injury after Cardiac Surgery: Incidence, Risk Factors and Prevention

BNP AND NGAL AS EARLY BIOMARKERS IN CARDIO-RENAL SYNDROME IN THE CRITICAL

Case - Acute Renal Failure

Appendix. Supplementary figures and tables

Acute kidney injury definition, causes and pathophysiology. Financial Disclosure. Some History Trivia. Key Points. What is AKI

PAEDIATRIC MANAGEMENT KDIGO. Uma Ramaswami FRCPCH, MD Royal Free London NHS Foundation Trust

Acute Kidney Injury. Eleanor Haskey BSc(hons) RVN VTS(ECC) VPAC A1

Use of Acute Kidney Injury Biomarkers in Clinical Trials

Pro-enkephalin and Renal Disease. Alan H. Wu, Ph.D. University of California, San Francisco 12 th Annual UCSD Biomarkers of Cardiac Disease

Use of Acute Kidney Injury Biomarkers in Clinical Trials

EXCRETION QUESTIONS. Use the following information to answer the next two questions.

Acute Kidney Injury (AKI) Undergraduate nurse education

Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE

AKI-6 Epidemiology of Acute Kidney Injury

Ruolo della clinica e del laboratorio nella diagnosi di IRA

Staging Sepsis for the Emergency Department: Physician

SEPSIS & SEPTIC SHOCK

BASELINE CHARACTERISTICS OF THE STUDY POPULATION

Veterinary Anaesthesia and Analgesia, 2016, 43,

Vasopressors in Septic Shock. Keith R. Walley, MD St. Paul s Hospital University of British Columbia Vancouver, Canada

Sepsis care and the new core measures

Sepsis Management: Past, Present, and Future

A Comparison Of Diagnostic Accuracy Of Cystatin C With Creatinine In The Sample Of Patient Of T2 DM With Diabetic Nephropathy

Sepsis Management Update 2014

Jill Vanmassenhove 1, Griet Glorieux 1, Norbert Lameire 1, Eric Hoste 2,3, Annemieke Dhondt 1, Raymond Vanholder 1 and Wim Van Biesen 1*

Measure Abbreviation: AKI 01 (QCDR Measure ID: ASPIRE19)

Urea Nitrogen (BUN) detection Kit

Doppler ultrasound, see Ultrasonography. Magnetic resonance imaging (MRI), kidney oxygenation assessment 75

When and how to start RRT in critically ill patients? Intensive Care Training Program Radboud University Medical Centre Nijmegen

Sepsis Care and the New Core Measures. Daniel S. Hagg, MD January 15, 2016

Prevention of Acute Renal Failure Role of vasoactive drugs and diuretic agents

Rationale for renal replacement therapy in ICU: indications, approaches and outcomes. Richard Beale

Comment on infusion solutions containing HES

Renal Protection in the Cardiac Surgery Patient: Peri-Operative Sodium Bicarbonate

Supplementary Online Content

Acute Kidney Injury in the ED

Proceeding of the LAVECCS

Understand the scope of sepsis morbidity and mortality Identify risk factors that predispose a patient to development of sepsis Define and know the

Biomarkers for optimal management of heart failure. Cardiorenal syndrome. Veli-Pekka Harjola Helsinki University Central Hospital Helsinki, Finland

Acute kidney injury (AKI) is considered an important

MAKING SENSE OF IT ALL AUGUST 17

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

AKI Risk Assessment, Prevention & Early Detection. Dr Lui G Forni Worthing Hospital, Brighton & Sussex Medical School

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Sepsis 3.0: The Impact on Quality Improvement Programs

Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes

Early Goal-Directed Therapy

Fluid Resuscitation and Monitoring in Sepsis. Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS

The Duration of Postoperative Acute Kidney Injury Predicts In-Hospital Mortality in Surgical Patients

Functional Renal Physiology and Urine Production

Blood purification in sepsis

VetScan UA Urine Analyzer Clinical Performance Larry Lem, PhD & Andrew Rosenfeld, DVM, ABVP

Research Article. NGAL as a biomarker to predict and diagnose Acute Kidney Injury (AKI)

Professor and Director. Children s Hospital of Richmond

Transcription:

Cortellini, S., Pelligand, L., Syme, H. M., Chang, Y. M., & Adamantos, S. E. (2015). Neutrophil Gelatinase-Associated Lipocalin in Dogs With Sepsis Undergoing Emergency Laparotomy: A Prospective Case-Control Study. Journal of Veterinary Internal Medicine, 29(6), 1595-1602. https://doi.org/10.1111/jvim.13638 Peer reviewed version Link to published version (if available): 10.1111/jvim.13638 Link to publication record in Explore Bristol Research PDF-document University of Bristol - Explore Bristol Research General rights This document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Full terms of use are available: http://www.bristol.ac.uk/pure/about/ebr-terms

1 1 2 3 4 Neutrophil gelatinase-associated lipocalin in dogs with sepsis undergoing emergency laparotomy: a prospective case-control study. 5 6 7 8 9 10 11 12 13 Authors: S. Cortellini a, L. Pelligand a,b, H. Syme a, Y.M Chang a and S. Adamantos c Corresponding author: S. Cortellini, Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire, AL9 7TA, UK. Affiliation: a Clinical Sciences and Services, Royal Veterinary College, North Mymms, UK 14 b Comparative Biomedical Sciences, Royal Veterinary 15 College, North Mymms, UK 16 c Langford Veterinary Services, University of Bristol, 17 18 19 20 21 22 23 Langford House, Langford, UK Running head: NGAL in dogs with sepsis Keywords: NGAL; AKI, acute kidney injury; canine Abbreviations: ACE: Angiotensin-converting enzyme AKI: acute kidney injury AKIN: Acute kidney injury network

2 24 25 26 27 28 29 30 31 32 33 APPLE: The acute patient physiologic and laboratory evaluation score MODS: Multiple organ dysfunction syndrome NGAL: Neutrophil gelatinase-associated lipocalin NSAID: Non steroidal anti-inflammatory drug RIFLE: Risk, injury, failure, loss of kidney function and endstage kidney disease. SIRS: Systemic inflammatory response syndrome UNCR: urinary NGAL normalized to creatinine VAKI: Veterinary acute kidney injury 34 35 36 37 38 39 40 41 The study was performed at the Queen Mother Hospital for Animals, Royal Veterinary College, London. This study was supported by a pump primer grant of from the Petplan Charitable Trust. Part of this study was presented as an abstract at the European Congress of Veterinary Emergency and Critical Care in Prague, 2014. 42 43 44 45 Abstract Background

3 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 Neutrophil gelatinase-associated lipocalin (NGAL) is an early indicator of acute kidney injury (AKI) in dogs and its use has not been evaluated in dogs with sepsis. Animals: Fifteen dogs with sepsis requiring laparotomy (study dogs) and 10 dogs undergoing surgery for intervertebral disc disease (control dogs). Objective: To determine whether NGAL increases in dogs with sepsis undergoing emergency laparotomy and whether it is correlated with development of AKI and survival. Methods: Longitudinal study conducted at a referral teaching hospital. Serum (sngal), urinary NGAL normalized to creatinine (UNCR) and serum creatinine concentration were measured at 4 time points (admission, after anesthesia, and 24 and 48 hours postsurgery). Development of AKI (increase in serum creatinine concentration of 0.3 mg/dl) and in hospital mortality were recorded. Linear mixed-model analysis was employed to assess differences between groups over time. Mann-Whitney U test was performed for comparison of continuous variables

4 68 69 70 71 72 73 74 75 76 77 78 79 80 81 between groups and Chi square or Fisher s exact tests were used to assess correlation between discrete data. Results Serum NGAL and UNCR were significantly higher in study dogs across all time points (p= 0.007 and p < 0.001 respectively) compared with controls. UNCR in the study group was not significantly different between survivors (n=12) and nonsurvivors (n=3). Dogs that received hydroxyethyl starch had significantly higher UNCR across all time points (p= 0.04) than those that did not. Discussion Conclusion sngal and UNCR are increased in dogs with sepsis requiring emergency laparotomy. Additional studies are needed to evaluate its role as a marker of AKI in this population. 82 83 Introduction 84 85 86 87 88 89 Acute kidney injury is defined as sudden injury to the renal parenchyma and reduction in renal function, regardless of underlying cause 1. In critical illness and in sepsis, AKI has been identified as one of the main contributors to morbidity and mortality in human patients. 2,3

5 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 The incidence of AKI in hospitalized septic dogs managed in an intensive care setting has been reported as 12% and the inhospital mortality rate for dogs with AKI varies from 54% to 86%. 4,5 No consensus has yet been reached in veterinary medicine however with regard to criteria that should be used to define kidney injury. There are several emerging classification systems available, including Veterinary Acute Kidney Injury staging system (VAKI) and Risk, Injury, Failure, Loss of kidney function and End-stage kidney disease (RIFLE)-like criteria. 4,6 The main pitfalls of the current systems are the use of insensitive and poorly specific markers, such as serum creatinine concentration or urine output. Serum creatinine concentration is not linearly related to GFR and can be influenced by factors other than renal function such as muscular mass and hydration state. 7 Glomerular filtration rate (GFR) is the gold standard for diagnosis of renal disease but this method, apart from not being readily clinically available, only detects reduction in renal function and not cellular injury, thus, leading to delayed recognition of disease. 1,8 Since the 1990 s, there has been a perceived need to identify early markers of AKI in order to identify at-risk patients. To this end, many biomarkers, such as N-acetyl-β-d-

6 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 glucosaminidase (NAG), kidney injury molecule-1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) have been studied in human and canine patients. 7,8 Neutrophil gelatinase-associated lipocalin is a 25 kda protein, belonging to the lipocalin family. It is covalently bound to gelatinase and secreted by neutrophils and normally is expressed at low concentrations in the kidney, lung, trachea and gastrointestinal tract. 9,10 It is freely filtered through the glomerulus and re-absorbed in the proximal tubule, such that healthy individuals usually have very low urinary excretion of NGAL. 11 Its production is highly upregulated when epithelial cell damage occurs. In clinical studies in people and dogs, its concentration in urine increases 24 to 72 hours before serum creatinine concentration, which enables earlier detection of AKI. 9,12,13 Neutrophil gelatinase-associated lipocalin can be measured in plasma, serum or in urine and it usually is expressed as an absolute concentration. In some studies, urinary NGAL has been normalized to urinary creatinine concentration in an attempt to decrease variation associated with changes in urine volume. 12,14,15 Plasma and urine NGAL is increased in people with sepsis and studies have shown an inconsistent ability for plasma or serum

7 135 136 137 138 NGAL to detect AKI in humans with severe sepsis or septic shock. 16-17 The ability of urinary NGAL to predict AKI recently has been evaluated in veterinary medicine. A number of clinical 139 studies, published in the last few years, have shown a 140 141 142 143 144 145 146 147 148 149 150 151 152 significantly higher urinary NGAL concentration in dogs with AKI compared to healthy dogs. 12-14 The aim of the present study was to evaluate the usefulness of both serum NGAL and urine NGAL normalized to urinary creatinine (UNCR) for detecting AKI in dogs with sepsis undergoing emergency laparotomy compared to dogs with intervertebral disc disease undergoing surgery. It was hypothesized that an increase in urinary NGAL concentration would be associated with development of AKI, longer time to discharge, increased morbidity (assessed by the Acute Patient Physiologic and Laboratory evaluation score [APPLE] full scoring system and Multiple organ dysfunction syndrome [MODS] criteria) and higher mortality. 153 154 155 156 157 Material and Methods The study was a prospective investigation performed on clientowned dogs. The protocol was approved by the Ethics and Welfare Committee of the Royal Veterinary College, London

8 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 (URN 2012 1155) and informed owner consent was obtained before enrolling each dog in the study. The study group included dogs with sepsis that were to undergo emergency laparotomy. Dogs initially were recruited if they fulfilled Systemic inflammatory response syndrome (SIRS) criteria (Table 1). 18 Dogs were included in the analysis if they fulfilled criteria for sepsis (i.e. presence of SIRS and confirmed or suspected infection). 19 Infection was defined as the presence of intracellular bacteria on cytological examination or microbiological evidence of infection in the abdominal fluid or aspirates from an abscess. Dogs with azotemia (defined as plasma or serum creatinine concentration > 1.57 mg/dl [138 µmol/l]) on presentation, or a history of chronic kidney disease, were excluded from the study. A control group of systemically healthy dogs undergoing emergency surgical intervention for intervertebral disk disease (IVDD) also was recruited. 175 176 177 178 179 180 Admission data Clinical data was collected on admission and included signalment, disease process, heart rate, respiratory rate, rectal temperature, systolic blood pressure, whole blood lactate concentration and serum creatinine concentration.

9 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 Hospitalization data Before or during the course of hospitalization, administration of vasopressors, hydroxyethyl starches, blood products, human serum albumin and potentially nephrotoxic drugs (e.g. non steroidal anti-inflammatory drugs [NSAID], angiotensinconverting enzyme [ACE]-inhibitors) were recorded. Occurrence of AKI, azotemia, hypotension and survival were recorded as categorical data. Acute kidney injury was defined as an increase in serum creatinine concentration of 0.3 mg/dl (26.4 µmol/l) within 48 hours, in keeping with the Acute kidney injury network (AKIN) criteria. 4 Serum creatinine concentration was measured on admission, post-anesthesia and 24 and 48 hours post-surgery. Hypotension was defined as a systolic Doppler pressure <90 mmhg or a mean invasive arterial pressure <60 mmhg. The APPLE full score on admission was calculated for each dog when data were available. 20 Multi-organ dysfunction syndrome was defined as 2 organ systems having signs of dysfunctions. 5 200 201 202 203 Sampling and sample processing Blood and urine samples were taken from dogs in both groups for NGAL and creatinine measurements. Samples were taken at

10 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 4 time points: (I) on admission, (II) after anesthesia (within 2 hours post-anesthesia), and (III) 24 and (IV) 48 hours postoperatively. Because ours was a clinical study performed in the United Kingdom on non-experimental animals, only residual volumes of blood taken from samples for clinical need could be used. Urine samples were collected by voiding or from an indwelling urinary catheter, and an aliquot of each fresh urine sample was submitted to the laboratory for urinalysis (refractometric urine specific gravity, dipstick semi-quantitative chemistry and sediment examination) and urine-protein-to-creatinine ratio (UP:C) measurement. c Pyuria was defined as 5 white blood cells per high power field. 21 Aliquots of the urine and serum samples were centrifuged at 400 g for 5 minutes and the supernatant frozen at -70 C within 1 hour (urine) and 8 hours (serum) for later batch analysis. Serum creatinine concentrations were determined from stored frozen serum samples using a biochemical analyzer. c Serum NGAL was measured on the same day using the same thawed samples. All samples thawed for NGAL analysis were re-frozen within 1 hour to allow for re-analysis if required. Urine and serum NGAL concentrations were determined using a sandwich ELISA a following the manufacturer s instructions d.

11 227 228 229 230 231 232 233 234 235 236 237 238 239 240 Urine and serum samples initially were diluted 1:200 using the diluent provided in the kit and the assay was performed according to the manufacturer s instructions. When necessary, dilution of the samples was adjusted (1:20 to 1:10000) to ensure that the NGAL concentration fell on the linear part of the standard curve. Samples requiring further dilution were thawed and frozen a maximum of 3 times. This thaw-refreeze process has been shown not to affect NGAL stability. 15 Urinary NGAL concentrations were normalized by the urinary creatinine concentration (mg/dl) to express results as UNCR. The final normalized ungal is expressed as ng/mg. A dual set of pooled quality control samples (high and low concentrations) also were included within each plate for assessment of inter-assay and intra-assay variability. 241 242 243 244 245 246 247 248 249 Statistics Statistical analyses were performed in SPSS e and figures were drawn using Graphpad Prism. f Continuous data was presented as median (range) in the original scale because some of the data have been log transformed in the statistical analysis and the sample size was small. Repeated measurement of UNCR and sngal were analyzed in a linear mixed-effects model (LMM) taking time, group (sepsis vs

12 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 control dogs), colloids, AKI, MODS, hypotension and blood product requirement as potential fixed effects and dog as random effect. Potential 2-way interactions between categorical fixed factors and time were assessed. A continuous variable was log transformed if its residuals from LMM analysis were skewed to the right. Although many continuous data were normally distributed, admission data between clinical course and treatment groups and survivors were compared using the Mann Whitney-U test because of the small sample size. Similarly, Spearman s correlation coefficient was used to measure linear correlation between 2 sets of continuous data to avoid the potential influence of outliers. The association between categorical variables was analyzed using Chi-squared or Fisher s exact test if the contingency table contained a value <5. Statistical significance was set at p < 0.05. 266 267 268 269 270 271 272 Results Recruitment and admission characteristics Twenty-one dogs were enrolled in the study group and 10 dogs were enrolled in the control group between June 2012 and August 2013. One dog in the study group subsequently was excluded because no urine had been stored for pre-surgery

13 273 274 275 276 277 278 279 280 281 NGAL analysis. Twenty dogs initially were included in the study. Five of these were removed because they did not fulfill criteria for sepsis. Four of these dogs had gastric dilatation and volvulus and 1 had severe gastroenteritis. The final study group therefore was represented by 15 dogs. Of these dogs, 13 had septic peritonitis and 2 had intra-abdominal abscessation. Admission variables and days of hospitalization were compared between the study and the control groups and reported in Tables 2 and 3. 282 283 284 285 286 287 288 289 290 Clinical course and treatment All dogs, in both the study and control groups, had blood pressure recorded over the course of the entire anesthetic period, and the study population had periodic blood pressure measurements made during hospitalization (Tables 2 and 3). Eleven of 15 dogs in the study group were hypotensive (4 preoperatively and 10 intra-operatively). Two of 3 non-survivors were hypotensive in the immediate post-operative period and 291 required vasopressor therapy. Blood pressure was not 292 293 294 measured on admission for any of the dogs in the control group because they were considered to be cardiovascularly stable based on clinical examination.

14 295 296 297 298 299 300 301 302 303 304 305 306 None of the dogs in the control group developed AKI whereas 2/15 (13%) dogs in the study group met AKI criteria but did not become azotemic (serum creatinine concentration increased by 0.57 mg/dl [50 µmol/l] and 0.65 mg/dl [57 µmol/l] in 24 hours). These 2 dogs later were euthanized because of clinical deterioration. No difference was identified between the incidence of AKI in the study and control groups (p= 0.5; Table 3). In the study population, 12 dogs (80%) survived to discharge, 1 dog died and 2 were euthanized after clinical deterioration. Nine dogs (90%) in the control group were discharged, with 1 being euthanized because of persistent paraplegia (Table 3). 307 308 309 310 311 312 313 314 315 316 317 Serum NGAL results Intra-assay and inter-assay variability for sngal was 2.0% and 10.4% for the high concentration quality control and 7.7 and 19.3% for the low concentration quality control, respectively. No significant difference was identified for time-group interaction and among times, but sngal was significantly higher in the study population compared to the control population (p= 0.007; Figure 1 and Table 4). A time-colloid administration interaction was present (p=0.01). The cause of significance seemed to derive mainly from difference between

15 318 319 320 321 time points within the non-colloid group, and there was no difference between colloid group at all time points (Table 4). There was no association between AKI, MODS development, hypotension and survival and sngal (Table 4). 322 323 324 325 326 327 328 329 330 331 332 333 334 335 UNCR results There was no time-group interaction and no difference among times for UNCR, but the study group had significantly higher UNCR than did the control dogs at all measured time points (p<0.001). No association was detected between UNCR and development of AKI (p = 0.25) or MODS (p= 0.49; Figure 2 and Table 4). Four of the 30 dogs (2 in each group) had pyuria. There was no association between UNCR and the presence of pyuria at any of the time points (p=0.55). None of the dogs in the control group was diagnosed with a urinary tract infection (UTI). One dog in the study group was diagnosed with a UTI, and this dog also had prostatic abscessation and septic peritonitis. 336 337 338 339 340 No time-colloids administration interaction was identified and no difference among time points was detected. Dogs that received hydroxyethyl starch g (12/30) however had significantly higher UNCR compared to dogs that did not across

16 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 all time points (p =0.04; Figure 3 and Table 4), with the 2 dogs that developed AKI receiving colloids, either preoperatively or intra-operatively. All dogs in the control group received NSAIDs after anesthesia, whereas none of the dogs in the study group received NSAIDs after admission. No time-nsaid administration interaction and no difference among times was detected, but dogs in the study group that did not receive NSAIDs before admission (n=11) had significantly higher UNCR (p=0.04; Table 4). There was a significant association between UNCR and days spent in the intensive care unit (ICU; Table 5) but no correlation was found between UNCR and duration of hospitalization (admission, p= 0.5; post-anesthesia, p =0.3; 24 hours, p= 0.34; 48 hours, p =0.09). No significant difference in UNCR was detected between dogs that survived to discharge and those that did not (p = 0.08). 357 358 359 360 361 362 Correlation There was moderate correlation between UNCR and sngal on admission (rs 0.76) and post-anesthesia (rs 0.82; Table 4). No correlation was found between UNCR and urinary ph and urine specific gravity (USG).

17 363 364 365 366 There was a correlation between UNCR and UP:C (admission, rs 0.61; post-anesthesia, rs 0.92; 24 hours, rs 0.87; 48 hours, rs 0.75) but no correlation was found between UNCR and APPLE full score at any of the time points (Table 4). 367 368 Discussion 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 Our study focused on detecting the effect of sepsis on sngal and UNCR and to assess their changes over the course of hospitalization. The control population was chosen to compare the effect of general anesthesia and surgery on NGAL in comparison to septic dogs undergoing emergency laparotomy. This group also was chosen because it theoretically allowed timed and non-invasive urine sampling because of routine placement of urinary catheters or bladder expression. Sepsis has been shown to be associated with development of AKI secondary to ischemia-reperfusion injury, damage induced by pro-inflammatory cytokines and oxidative stress and tubular dysfunction leading to decreased glomerular filtration and tubular reabsorbtion dysregulation. 22 Neutrophil gelatinase associated lipocalin is secreted by neutrophils and it is therefore logical to expect an increase in its concentration in inflammatory states. In particular, during sepsis, NGAL

18 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 expression increases, not only in the kidney, but also in leukocytes and liver. Therefore, higher NGAL both in blood and in urine are expected, regardless of AKI. 11 A study in human patients showed that sngal was increased in patients with sepsis, severe sepsis and septic shock, but was not able to detect AKI in this population, especially in the sicker categories. 16 The results of the present study confirm that sngal also in increased in dogs with sepsis compared to a control population. However, sngal was not associated with mortality or correlated with the severity of the disease, as assessed by the APPLE scoring system or MODS development, suggesting that this marker may not be a useful clinical severity predictor. The UNCR differed between the study and control groups across all time points evaluated (p < 0.001). The median UNCR concentration in the study group post-anesthesia was as high as 114 times (admission) and 185 times higher than in the control group, highlighting the marked difference between the 2 groups. However, similar to sngal, UNCR was not associated with mortality, suggesting that this marker may not be useful to assess the severity of disease. A study in people showed that septic AKI patients had higher urinary NGAL than non-septic AKI patients. 23 Both sngal and

19 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 UNCR were not associated with AKI development over the course of hospitalization in this study. This finding may be a consequence of the inability of NGAL to distinguish between the presence of AKI and systemic inflammation in septic dogs, and as a result may suggest that NGAL is a poor marker of AKI in this population of dogs. The lack of significance to detect AKI, however, could have been a result of the small population size and thus indicate a type II error. Neutrophil gelatinase associated lipocalin increases 3 hours after ischemic renal injury in people undergoing cardiopulmonary bypass and peaks at 36 hours in critically ill patients developing AKI during hospitalization. 24 However NGAL has been shown to increase up to 72 hours earlier than serum creatinine concentration in the event of AKI. Therefore, this study may not have detected an increase in serum creatinine concentration if it occurred after the 48 hours sample, potentially leading to AKI recognition being missed in some patients. 10,23 This time window was selected based on evidence in human patients showing that adverse outcome is associated with increased serum creatinine concentration within 48 hours, and the immediate post-operative period was deemed most appropriate to detect eventual development of AKI. 13,25

20 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 The increase in UNCR in dogs with sepsis in our study perhaps represents sub-clinical AKI, not detected by the VAKI system, or may have been related to an increase in serum creatinine concentrations that occurred after 48 hours. 4 The increase in serum creatinine concentration used to define AKI in our study was considered to be a sensitive way of identifying these dogs. However, serum creatinine concentration may not be altered in the event of tubular injury, indicated by an increase in NGAL production, because the GFR of the affected nephrons may not be altered or overall renal compensation may occur in other nephrons. Conversely, tubular injury, detected by an increase in NGAL concentration, may lead to a decrease in glomerular function as a consequence of tubular flow obstruction and tubulo-glomerular interaction. 26 In this situation, NGAL may not be correlated with GFR, and its increase does not consistently reflect a change in serum creatinine concentration. It is unlikely that the difference in UNCR between the 2 groups was a consequence of altered passage of NGAL across the glomerular filtration barrier. In fact, although there was an association between UP:C and UNCR, sngal and UNCR were only moderately correlated on admission and post-anesthesia. It appears more likely that in severe inflammation renal derangements lead to decreased re-absorptive capacity in the

21 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 proximal tubules or up-regulation of NGAL production at the level of the thick ascending loop, distal tubule and collecting ducts. 10 One study showed that, in dogs undergoing surgery, urinary NGAL was significantly higher in dogs with AKI 12 hours postoperatively, whereas plasma NGAL was not able to detect AKI. 13 Another study in dogs with a variety of diseases, including heatstroke and snake envenomation, showed that UNCR on admission was significantly higher in dogs with AKI (grade I to V) and detected AKI earlier than the increase in plasma creatinine concentration. 12 However, 9 of 15 dogs (60%) in our study had UNCR results on admission higher than the cut-off of 238 ng/mg established by a previous study for distinguishing non-azotemic AKI grade I patients from dogs with related renal or urinary conditions. 12 However, the pathophysiology of AKI in sepsis is substantially different from other causes of AKI, such as ischemia or toxic damage, and NGAL expression is upregulated in inflammatory conditions, such as infection. 21,22 Of the 9 dogs with UNCR >238 ng/mg, only 2 developed AKI and none of them developed azotemia. This cut-off may therefore not be useful in dogs with sepsis and additional studies are needed to establish a cut-off for this population. Both UNCR and sngal were not significantly associated with

22 478 479 480 481 482 483 time to discharge but were associated with ICU stay. Timing of discharge and ICU hospitalization are clinician-dependent and financially-based decisions and these factors might have influenced this result. In addition, our control population was represented by patients with IVDD, which have predictably long hospitalization times. 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 Patients that did not receive NSAIDs before admission had higher UNCR compared to patients that did across all time points. This difference may have been simply a consequence of more severe disease in dogs not receiving NSAIDs, because there currently is no evidence that NSAIDs may induce urinary NGAL down-regulation. An interesting finding was the significant difference in UNCR between dogs that received colloids and dogs that did not. The higher UNCR in dogs that received colloids was consistent across all 4 time points, and UNCR was increased before surgery although only 4 of the 9 dogs were given colloids on admission, whereas 4 received them intra-operatively and 1 post-operatively. This difference may simply reflect a difference in severity of illness, because colloids typically are used more often in dogs with more serious signs of hypoperfusion and potentially more severe inflammation. This

23 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 may have induced an up-regulation of NGAL secretion and an increase in UNCR independent of colloid administration. 11 In people, hydroxyethyl starches are associated with increased risk of kidney injury, and recent studies have highlighted an association between the use of hydroxyethyl starches (including pentastarch and tetrastarch) and kidney injury or renal replacement therapy requirement. 27,28 Usually, an increase in ungal is expected to occur at least 3 hours after the renal injury. 11 If these artificial colloids induced AKI in the dogs of our study, a difference at the pre-anesthesia sample would not be expected, because most patients did not receive hydroxyethyl starches until intra-operatively or postoperatively. The results of our study should therefore be interpreted with caution. One limitation of this study is that there were 21/100 urine samples and 40/100 serum samples missing. Analysis of all of the samples may have added further information to our analysis and allowed better interpretation of the data. The absence of results, in addition to the small number of cases enrolled, therefore may have caused the analysis to be underpowered. A second limitation involves the choice of the control group. The median admission data for this group was not significantly

24 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 different from that of the study group, leading to a potential confounding overlap within the population (Tables 1 and 2). However, the underlying diseases affecting the 2 groups were substantially different, being localized in the control dogs and systemic and pro-inflammatory in the study patients. Additional studies may benefit from the use of more stringent SIRS criteria, allowing clear clinical distinction between the control and the study group on admission. In addition, our study monitored serum creatinine concentration for a 48-hours period. Because NGAL may increase up to 72 hours earlier than serum creatinine concentration in the event of renal injury, some patients with AKI may have been missed. 11,24. A further limitation includes the clinician-based decision for administration of hydroxyethyl starches, blood products or institution of vasopressor therapy, rendering objective interpretation of these data or assessment of the severity of illness difficult. It also is currently unknown whether drugs, such as human serum albumin, may affect serum and urinary NGAL release and tubular re-absorption, interfering with the results of the study. Additional prospective studies with larger populations of dogs with sepsis and use of additional urinary markers are

25 547 548 warranted to assess the association between NGAL and inflammation, sepsis and AKI. 549 550 551 552 553 554 555 556 557 558 559 Footnotes: a. Dog NGAL ELISA kit, BioPorto Diagnostics, Gentofte, Dk. b. Tecn Sunrise Elisa-reader; Tecan Group, Mannedorf, Ch c. IL600, Instrumentation Laboratory Cheshire, UK d. http://ngal.com/media/44324/kit_043_ifu_ruo.pdf e. SPSS version 20, Chicago, Ill, USA f. Graphpad Prism, version 6, La Jolla, Ca, USA g. Voluven (6% Hydroxyethyl Starch 130/0.4 in 0.9% Sodium Chloride), Fresenius Kabi Norge A.S., Halden Norway 560 561 562 563 564 565 566 567 Bibliography: 1. Waikar S.S, Liu K.D, Chertow G.M. Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol 2008; 3: 844-861. 2. Uchino S, Kellum J.A, Bellomo R et al. Acute renal failure in critically ill patients: a multinational, multi-center study. JAMA, 2005, 294 (7): 813-8.

26 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 3. Bagshaw S.M, Uchino S, Bellomo R et al. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol, 2007; 2 (3): 431-9. 4. Thoen M.E, Kerl M.E. Characterization of acute kidney injury in hospitalized dogs and evaluation of a veterinary acute kidney injury staging system. J Vet Emerg Crit Care (San Antonio) 2011;21: 648-657. 5. Kenney E.M, Rozanski E.A, Rush J.E et al. Association between outcome and organ system dysfunction in dogs with sepsis: 114 cases (2003-2007). J Am Vet Med Assoc. 2010;236(1):83-7. 6. Lee Y.J, Chang C.C, Chan J.P et al. Prognosis of acute kidney injury in dogs using a RIFLE (Risk, Injury, Failure, Loss and End-stage renal failure)-like criteria. Vet Rec. 2011; 168(10):264. 7. Cobrin A.R, Blois S.L, Kruth S.A et al. Biomarkers in the assessment of acute and chronic kidney disease in the dog and cat. J Small Anim Pract. 2013;54(12):647-55. 8. Ostermann M, Philips B.J and Forni L.G. Clinical review. Biomarkers of acute kidney injury: where are we now?. Crit Care. 2012;16(5):233. 588 589 590 9. Hilde R.H, Woo J.G, Wang Y et al. Urinary neutrophil gelatinase- associated lipocalin measured on admission to the intensive

27 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 care unit accurately discriminates between sustained and transient acute kidney injury in adult critically ill patients. Nephron Extra. 2011;1(1):9-23. 10. Goetz D.H, Holmes M.A, Borregaard N et al. The Neutrophil Lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell. 2002;10(5):1033-43. 11. Singer E, Markò L, Paragas N et al. Neutrophil gelatinaseassociated lipocalin: pathophysiology and clinical applications. Acta Physiol (Oxf). 2013;207(4):663-72. 12. Segev G, Palm C, LeRoy B. et al. Evaluation of Neutrophil gelatinase-associated lipocalin as a marker of kidney injury in dogs. J Vet Intern Med. 2013;27(6):1362-7. 13. Lee Y.J, Hu Y.Y, Lin Y.S et al. Urine neutrophil gelatinaseassociated lipocalin (NGAL) as a biomarker for acute canine kidney injury. BMC Vet Res. 2012 28;8:248. 14. Steinbach S, Weis J, Schweighauser A et al. Plasma and urine neutrophil Gelatinase-Associated Lipocalin (NGAL) in dogs with acute kidney injury or chronic kidney disease. J Vet Intern Med. 2014;28(2):264-9. 15. Nabity M.B, Lees G.E, Cianciolo R et al. Urinary biomarkers of renal disease in dogs with X-linked hereditary nephropathy ; J Vet Intern Med. 2012 Mar-Apr;26(2):282-93.

28 614 615 616 617 618 619 620 621 622 623 624 625 626 627 16. Mårtenson J, Bell M, Oldner A et al. Neutrophil gelatinaseassociated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med. 2010;36(8):1333-40. 17. Wheeler D.S, Devarajan P, Ma Q et al. Serum Neutrophil Gelatinase-associated Lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med. 2008;36(4):1297-303. 18. Hauptman J.C, Walshaw R and Olivier N.B. Evaluation of the Sensitivity and Specificity of Diagnostic Criteria for Sepsis in Dogs. Vet Surg. 1997;26(5):393-7. 19. Dellinger R.P, Levy M.M, Rhodes A et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013; 41(2):580-637. 628 629 630 631 632 633 634 635 636 20. Hayes G, Mathews K, Doig G et al. The Acute patient physiologic and laboratory evaluation (APPLE) score: a severity of illness stratification system for hospitalised dogs. J Vet Intern Med. 2010;24(5):1034-47. 21. Daure E, Belanger M.C, Beauchamp G et al. Elevation of neutrophil gelatinase-associated lipocalin (NGAL) in nonazotemic dogs with urinary tract infection. Res Vet Sci. 2013;95(3):1181-5.

29 637 22. 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 Keir I. and Kellum J.A. Acute kidney injury in severe sepsis: pathophysiology, diagnosis, and treatment recommendations. JVECC, 2015; 25 (2): 200-209. 23. Bagshaw S.M, Bennett M, Haase M et al. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus nonseptic acute kidney injury in critical illness. Intensive Care Med. 2010;36(3):452-61. 24. Mishra J, Dent C, Tarabishi R et al. Neutrophil gelatinaseassociated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365(9466):1231-8. 25. Mehta R.L, Kellum J.A, Shah S.V. et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2). 26. Basile D.P, Anderson M.D and Sutton T.A. Pathophysiology of acute kidney injury. Compr Physiol. 2012; 2(2): 1303 1353. 27. Perner A, Haase N, Guttormsen M.D et al. Hydroxyethyl Starch 130/0.42 versus Ringer's Acetate in Severe Sepsis. N Engl J Med. 2012;367(2):124-34. 28. Zarichanski R, Abou-Setta A.M, Turgeon A.F et al. Association of Hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume

30 659 660 resuscitation. A systematic review and meta-analysis JAMA. 2013; 309(7):678-88. 661 662 663 664 665 Legends: Table 1: Systemic Inflammatory Response Syndrome (SIRS) criteria used for inclusion of dogs within the study group. SIRS was defined if patients fulfilled 2 or more criteria. 18 666 667 668 669 670 Table 2: Measurements taken at admission and hospitalization time between study and control patients. Measurements are expressed as median (range) and statistical significance was set at P<0.05. NA= not applicable; R.I.: Reference Interval. 671 672 673 674 675 676 677 678 679 680 Table 3: Pre-admission treatment, clinical course and treatment received in the study and in the control dogs. Significant differences are highlighted (significance set at a p value 0.05). APPLE score was calculated. 20 MODS (Multi-Organ Dysfunction Syndrome) was defined as dysfunction of at least two organs. 5 AKI (Acute Kidney Injury) was defined as an increase of 0.3 mg/dl (26.5 µmol/l) from baseline. 4 681

31 682 683 684 685 686 Table 4: Differences in the normalized sngal and UNCR for each single category and differences between time and timecategory interaction. Significant difference was set at p< 0.05. AKI: acute kidney injury; NSAID: non steroidal antiinflammatory drug; MODS: Multi-organ dysfunction syndrome. 687 688 689 690 Table 5: Spearman s correlation (rs) between UNCR and UP:C, serum creatinine, sngal, day in I.C.U and APPLE score. Statistical significance was set at p < 0.05. 691 692 693 694 695 696 697 698 699 700 Figure 1: The medians and interquartile range of serum NGAL at different times between the control and the study group are represented by the bar and the whiskers with all the patients displayed in a scattered plot manner. The two AKI patients are represented by x and on the graph. sngal concentrations were significantly higher across all time points in the study group. 701 702 703 704 Figure 2: The medians and interquartile ranges of urinary NGAL to creatinine ratio (UNCR) at different times between the control and the study group are expressed by the bar and the

32 705 706 707 708 whiskers respectively with the single patients displayed in a scatter plot manner. The two patients with AKI have been identified with x and. The study group had significantly higher UNCR across all the time points (p < 0.001). 709 710 711 712 713 714 715 716 Figure 3: The medians and interquartile ranges of urinary NGAL to creatinine ratio (UNCR) at different times between patients that received colloids and patients that did not are expressed by the bar and the whiskers respectively with the single patients displayed in a scatter plot manner. Statistical significance was set at P<0.05. Dogs that received colloids had significantly higher UNCR concentration across all time points. Variable Heart rate Respiratory rate Body temperature White blood cell count Increased band neutrophils with SIRS criteria fulfilled if >120/min >20/min <38.1 C or >39.2 C <6x10 3 or >16x10 3 /µl 3% normal neutrophil count 717 718 719 Table 1: Systemic Inflammatory Response Syndrome (SIRS) criteria used for inclusion of dogs within the study group; SIRS was defined if patients fulfilled 2 or more criteria. 18 720

33 721 Study Control p value Heart rate (bpm) 128 (70-190) 120 (80-172) 1 Respiratory rate (rpm) 36 (20-100) 40 (20-80) 0.69 Temperature ( C) 39.2 (37.8-40.7) 38.8 (36.9-39.4) 0.36 White Blood cells (10 9 ) 17.3 (2.2-47.8) - - Lactate (mg/dl) (R.I. 0-22.5) 11.7 (6.3-99) (n=15) 16.2 (16.2-18) (n=3) 0.2 Doppler systolic blood pressure (mmhg) 130 (60-170) - - 722 723 724 725 Table 2: Measurements taken at admission between study and control patients. Measurements are expressed as median (range) and statistical significance was set at P<0.05. NA= not applicable; R.I.: Reference Interval. 726 727 728 729

34 Study Control P Value Admission characteristic Previous surgery (5 days) 5/15 (33%) 0/10 (0%) 0.61 Fluid therapy prior admission (crystalloids) 13/15 (86%) Non steroidal antiinflammatory medications 4/15 (27%) 1/10 (10%) < 0.01 6/10 (60%) 0.12 Clinical Course Hypotension 11/15 (73%) 0/10 (0%) < 0.01 APPLE score 28 (8-38) (14/15).. MODS 4/15 (27%) 0/10 (0%) 0.12 AKI 2/15 (13%) 0/10 (0%) 0.5 Survival to discharge 12/15 (80%) 9/10 (90%) 0.62 Treatment Blood products 5/15 (33%) 0/10 (0%) 0.06 Human serum albumin 3/15 (20%) 0/10 (0%) 0.25 Hydroxyethyl starch (Voluven ) 9/15 (60%) 0/10 (0%) <0.01

35 Days Hospitalization 7(1-11) 12.5 (1-11) 0.42 Days ICU 3 (1-11) 0 (0-0) < 0.01 730 731 732 733 734 735 736 737 738 Table 3: Pre-admission treatment, clinical course and treatment received in the study and in the control dogs. Significant differences are highlighted (significance set at a p value 0.05). APPLE score was calculated. 20 MODS (Multi-Organ Dysfunction Syndrome) was defined as dysfunction of at least two organs. 5 AKI (Acute Kidney Injury) was defined as an increase of 0.3 mg/dl (26.5 µmol/l) from baseline. 4 739 740 741 Category Category Time Time-category interaction sngal Sepsis p= 0.007 p= 0.13 p = 0.95 AKI p= 0.28 p= 0.24 p= 0.83 Hypotension P= 0.49 p= 0.23 p= 0.33 Survival p= 0.09 p= 0.25 p= 0.34 NSAIDs p= 0.12 p= 0.23 p= 0.47 Colloids p=0.72 p= 0.16 p= 0.01 MODS p= 0.49 p= 0.24 p= 0.57 Blood products p= 0.96 p= 0.24 p= 0.43 UNCR Sepsis p< 0.001 p= 0.29 p= 0.12 AKI p= 0.25 p= 0.1 p= 0.5 Hypotension p= 0.55 p= 0.08 p= 0.75 Survival p= 0.08 p= 0.11 p= 0.19 NSAIDs p= 0.04 p= 0.08 p= 0.21 Colloids p= 0.04 p= 0.12 p= 0.07 MODS p= 0.49 p= 0.08 p= 0.44 Blood products p= 0.21 p= 0.1 p= 0.07 Table 4: Differences in sngal and UNCR for each single category and differences between time and time-category interaction. Significant difference was set at p< 0.05. AKI: acute

36 742 743 kidney injury; NSAID: non steroidal anti-inflammatory drug; MODS: Multi-organ dysfunction syndrome. 744 745

37 746 UP:C Serum Creatinine sngal DAYS I.C.U. APPLE score UNCR admission UP:C adm p < 0.001; rs 0.61 Creat adme p = 0.17 sngal adm p < 0.01; rs 0.76 p< 0.001; rs 0.7 p= 0.44 UNCR post UP:C post p < 0.001; rs 0.92 Creat. post p=0.03; rs 0.54 sngal. post p < 0.01; rs 0.82 p< 0.001; rs 0.77 p= 0.71 UP:C 24 p< 0.001; rs UNCR 24 p < 0.001; rs 0.87 Creat. 24 p = 0.11 sngal 24 p= 0.07 0.79 p= 0.08 UP:C 48 p< 0.001; rs UNCR 48 p= 0.001; rs 0.75 Creat. 48 p = 0.15 sngal. 48 p = 0.33 0.77 p = 0.2 747 748 749 750 Table 5: Spearman s correlation (rs) between UNCR and UP:C, serum creatinine, sngal, day in I.C.U and APPLE score. Statistical significance was set at p < 0.05. 751

38 752 753 754 755 756 757 758 759 760 761 Figure 1: The medians and interquartile ranges of serum NGAL at different times between the control and the study group are represented by the bar and the whiskers with all the patients displayed in a scattered plot manner. The two AKI patients are represented by x and on the graph. Serum NGAL concentrations were significantly higher across all time points in the study group. 762 763 764

39 765 766 767 768 769 770 Figure 2: The medians and interquartile ranges of urinary NGAL to creatinine ratio (UNCR) at different times between the control and the study group are expressed by the bar and the whiskers respectively with the single patients displayed in a scatter plot manner. The two patients with AKI have been identified with x and. The study group had significantly higher UNCR across all the time points (p < 0.001). Statistical significance was set at p<0.05. 771 772 773

40 774 775 776 777 778 779 780 Figure 3: The medians and interquartile ranges of urinary NGAL to creatinine ratio (UNCR) at different times between patients that received colloids and patients that did not are expressed by the bar and the whiskers respectively with the single patients displayed in a scatter plot manner. Statistical significance was set at P<0.05. Dogs that received colloids had significantly higher UNCR concentration across all time points. 781

782 41